| Nanoemulsions in translational research—opportunities and challenges in targeted cancer therapy S Ganta, M Talekar, A Singh, TP Coleman, MM Amiji Aaps Pharmscitech 15, 694-708, 2014 | 232 | 2014 |
| Mitochondrial biology, targets, and drug delivery L Milane, M Trivedi, A Singh, M Talekar, M Amiji Journal of controlled release 207, 40-58, 2015 | 167 | 2015 |
| Targeting of nanoparticles in cancer: drug delivery and diagnostics M Talekar, J Kendall, W Denny, S Garg Anti-cancer drugs 22 (10), 949-962, 2011 | 149 | 2011 |
| Silica nanoparticles: A promising platform for enhanced oral delivery of macromolecules MM Abeer, P Rewatkar, Z Qu, M Talekar, F Kleitz, R Schmid, M Lindén, ... Journal of controlled release 326, 544-555, 2020 | 81 | 2020 |
| Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy B Zeng, APJ Middelberg, A Gemiarto, K MacDonald, AG Baxter, M Talekar, ... The Journal of clinical investigation 128 (5), 1971-1984, 2018 | 80 | 2018 |
| Modification of tumor cell exosome content by transfection with wt-p53 and microRNA-125b expressing plasmid DNA and its effect on macrophage polarization M Trivedi, M Talekar, P Shah, Q Ouyang, M Amiji Oncogenesis 5 (8), e250-e250, 2016 | 77 | 2016 |
| Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases A Singh, M Talekar, A Raikar, M Amiji Journal of controlled release 190, 515-530, 2014 | 75 | 2014 |
| Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems PT Koh, JN Chuah, M Talekar, A Gorajana, S Garg Indian journal of pharmaceutical sciences 75 (3), 291, 2013 | 69 | 2013 |
| Combinatorial approach in the design of multifunctional polymeric nano-delivery systems for cancer therapy A Singh, M Talekar, TH Tran, A Samanta, R Sundaram, M Amiji Journal of materials chemistry B 2 (46), 8069-8084, 2014 | 58 | 2014 |
| PD-L1–and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease R Galea, HJ Nel, M Talekar, X Liu, JD Ooi, M Huynh, S Hadjigol, ... JCI insight 4 (18), 2019 | 57 | 2019 |
| Combination wt-p53 and MicroRNA-125b transfection in a genetically engineered lung cancer model using dual CD44/EGFR-targeting nanoparticles M Talekar, M Trivedi, P Shah, Q Ouyang, A Oka, S Gandham, MM Amiji Molecular Therapy 24 (4), 759-769, 2016 | 56 | 2016 |
| Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery M Talekar, SR Boreddy, A Singh, M Amiji Expert opinion on biological therapy 14 (8), 1145-1159, 2014 | 50 | 2014 |
| Knowledge and reported use of antibiotics amongst immigrant ethnic groups in New Zealand P Norris, LF Ng, V Kershaw, F Hanna, A Wong, M Talekar, J Oh, M Azer, ... Journal of immigrant and minority health 12, 107-112, 2010 | 50 | 2010 |
| Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer M Talekar, Q Ouyang, MS Goldberg, MM Amiji Molecular cancer therapeutics 14 (7), 1521-1531, 2015 | 47 | 2015 |
| Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis MR Maradana, SK Yekollu, B Zeng, J Ellis, A Clouston, G Miller, ... Metabolism 78, 80-94, 2018 | 44 | 2018 |
| Inhibition of hexokinase-2 with targeted liposomal 3-bromopyruvate in an ovarian tumor spheroid model of aerobic glycolysis SK Gandham, M Talekar, A Singh, MM Amiji International journal of nanomedicine, 4405-4423, 2015 | 43 | 2015 |
| Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian … M Talekar, S Ganta, A Singh, M Amiji, J Kendall, WA Denny, S Garg Pharmaceutical research 29, 2874-2886, 2012 | 43 | 2012 |
| Translational nano-medicines: targeted therapeutic delivery for cancer and inflammatory diseases M Talekar, TH Tran, M Amiji The AAPS journal 17, 813-827, 2015 | 42 | 2015 |
| Regulatory T cells induced by single-peptide liposome immunotherapy suppress islet-specific T cell responses to multiple antigens and protect from autoimmune diabetes AS Bergot, I Buckle, S Cikaluru, JL Naranjo, CM Wright, G Zheng, ... The Journal of Immunology 204 (7), 1787-1797, 2020 | 41 | 2020 |
| Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy M Talekar, S Ganta, M Amiji, S Jamieson, J Kendall, WA Denny, S Garg International journal of pharmaceutics 450 (1-2), 278-289, 2013 | 40 | 2013 |
